drugset / Trial / NCT01526564

Clinical Study on Acetyl-L-Carnitine

NCT01526564

RandomizedParallel-groupDouble-blindTreatment

Summary

Chemotherapy-induced peripheral neuropathy (CIPN) is a common clinical dose-limiting adverse drug reaction, and the primary manifestations are different degree of neuromotor, sensorineural and autonomic nervous dysfunction.

Timeline

Start
2008-08
Primary completion
2011-04
Completion
2011-07

Drugs

EvaluationDrugModalityDoseRoute
Comparator Acetylcarnitine Small molecule 1 g Oral